Ashita Batavia

Head of Hematology & Oncology Data Sciences, R&D, Johnson & Johnson Innovative Medicine

Ashita S. Batavia, MD MS is Head of Hematology Oncology Data Sciences for Johnson & Johnson Innovative Medicine. She is an industry leader in using Data Sciences to accelerate drug development. She was previously at McKinsey & Co. where she counseled Fortune 50 Executives on precision medicine and using advanced analytics to drive impact. Dr Batavia is an Assistant Professor at Weill Cornell Medicine and has been a practicing physician for over 15 years. She has received numerous research awards and has multiple peer-reviewed publications. Dr. Batavia is passionate about using data and technology to improve the health of patients.

Kailee Hawkins

Clinical Research Manager, Alabama Oncology

Kailee Hawkins, MS is an accomplished Clinical Research Professional with over 10 years of experience, specializing in community oncology and regulatory compliance. Prior to her current role at Alabama Oncology, Kailee held regulatory compliance positions at both Vanderbilt University Medical Center and the University of Alabama at Birmingham. As the Clinical Research Manager at Alabama Oncology, Kailee has led initiatives to embrace technology, and drive process improvement leading to consistent growth in the research department. Kailee is also recognized by the American Cancer Society as a distinguished young professional in the Birmingham community

Tara Marti

Precision Oncology Portfolio Sr Manager, MRD, Exact Sciences

Tara Marti is Precision Oncology Portfolio Sr. Manager, MR, for Exact Sciences where she is a leader in evidence generation and product development strategy. Tara is passionate and a collaborative problem-solver who values the opportunity to think beyond the way things are. Tara developed the protocol for Exact Science's first prospective precision oncology clinical validation study. Before Exact Sciences, Tara was the research supervisor at Decipher overseeing the acquisition and processing of thousands of study samples and data to validate their prostate cancer prognostic signature. Tara is a certified molecular biologist and CAP inspector with a bachelor's degree in microbiology from the University of Wisconsin-La Crosse.

moderator

Lockwood Taylor

Senior Director, Head of Regulatory Strategy, Flatiron Health

Lock Taylor, PhD, MPH is Head of Regulatory Strategy at Flatiron Health, where he leads a team of regulatory experts who advise clients on evidence generation and regulatory considerations to optimize regulatory success. An epidemiologist by background, Dr. Taylor has over 15 years of experience in leading observational studies of medication safety and effectiveness. Lock spent 7 years at the U.S. Food and Drug Administration, most recently as a Deputy Director in CDER's Office of Surveillance and Epidemiology, where he led regulatory-focused research and was involved in RWE guidance development. Additionally, Lock held a position as an epidemiologist within the Office of the U.S. Army Surgeon General, where he led observational studies of medication safety and worked in adverse event signal detection supporting military pharmacovigilance efforts. Immediately prior to Flatiron, Lock spent 5 years at IQVIA leading pharmacoepidemiologic research studies, developing innovative and fit-for-purpose RWE solutions, and providing clients with regulatory strategy in pre- and post-approval settings across a diversity of medical products.

Dr. Taylor received his PhD from the University of Texas School of Public Health and currently holds an adjunct faculty appointment at Georgetown University Medical Center's Department of Biostatistics, Bioinformatics & Biomathematics.